SYNVISC-ONE
Live / Registered — Registered and renewed (as of 12 Sept 2019)
What this means for you
Registered since 07 Jul 2009. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (next due by 07 Jul 2019).
Record
- Serial number
- 77171858
- Registration number
- 3651732
- Mark type
- Stylized text
- Filed
- 03 May 2007
- Published for opposition
- 28 Aug 2007
- Registered
- 07 Jul 2009
- Next maintenance due
- 07 Jul 2019
- Attorney of record
- Karen Lim
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical, namely, pre-packaged injectable biochemical solutions, namely, sodium hylan solutions
- Class 010 — Medical apparatus: Medical Apparatus, namely, a self-contained syringe for dispensing prepackaged injectable sodium hylan solutions for use in surgery
Owner
- Genzyme Corporation, Cambridge, MA, US
- Genzyme Corporation, Cambridge, MA, US
- Genzyme Corporation, Cambridge, MA, US
Prior registrations
Prosecution history
- 08 Jan 2020 — REVIEW OF CORRESPONDENCE COMPLETE - ADDRESS UPDATED
- 10 Dec 2019 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 12 Sept 2019 — NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
- 12 Sept 2019 — REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
- 12 Sept 2019 — REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
- 12 Sept 2019 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 31 Jul 2019 — TEAS SECTION 8 & 9 RECEIVED
- 12 Apr 2019 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
- 12 Apr 2019 — TEAS CHANGE OF OWNER ADDRESS RECEIVED
- 07 Jul 2018 — COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
- 05 Apr 2017 — REVIEW OF CORRESPONDENCE COMPLETE - ADDRESS UPDATED
- 31 Jan 2017 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 27 Nov 2015 — NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
- 27 Nov 2015 — REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
- 20 Nov 2015 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL